EKSO faces severe financial distress with cash plummeting 82% to just $1.2M while gross profit declined 28% and operating losses widened significantly.
The dramatic cash burn combined with widening operating losses creates an immediate liquidity crisis that threatens the company's ability to continue operations without additional funding. With only $1.2M in cash remaining and mounting losses, EKSO will likely need to raise capital urgently or face potential bankruptcy.
EKSO's financial position deteriorated across all major metrics, with the most alarming being the 82% collapse in cash to just $1.2M alongside a 28% decline in gross profit to $6.8M. Operating losses widened to -$13.3M despite R&D expense reductions, while interest expense nearly doubled and capital expenditures surged 408%, indicating the company is burning through its remaining resources at an unsustainable rate. The overall picture signals acute financial distress requiring immediate capital infusion to avoid insolvency.
SG&A up 860.5% — significant increase in sales or administrative costs, monitor impact on operating leverage.
Capital expenditure jumped 408.1% — major investment cycle underway; assess returns on deployment.
Interest expense surged 93.6% — significant debt increase or rising rates materially impacting earnings.
Cash declined 82% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Equity decreased 29% — buybacks or losses reducing book value, monitor solvency ratios.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
Current assets declined 25.4% — monitor working capital adequacy and short-term liquidity.
Total assets contracted 24.5% — asset sales, write-downs, or balance sheet optimization underway.
R&D spending cut 21.8% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →